-
Aston Villa want to be more than a 'maybe team' in quest for Europa League
-
Trump administration takes steps to curb energy cost hikes
-
Vaccines facing misinformation spike: WHO experts
-
'Happened so fast': UK students panicked by meningitis outbreak
-
WNBA, players union agree 'transformative' labor deal: reports
-
Global music market grows, calls for AI compensation: industry body
-
Maiduguri bombings follow surge of jihadist violence in Nigeria
-
Belgian court suspends TotalEnergies climate trial
-
Troubled waters: Thai fishermen marooned by rising fuel costs
-
Doku adamant Man City still have plenty to play for after Champions League exit
-
Afghanistan vows to avenge deadly Kabul bombing but says open to talks
-
Stocks fall, oil surges as US inflation jumps and Israel strikes gas facilities
-
Nigerian president meets royals on 'historic' UK state visit
-
South Lebanon residents flee death and destruction
-
Buttler ready to continue England career despite 'poor' T20 World Cup
-
Why convoys cannot fully protect oil tankers from Iran attacks
-
UK PM leads efforts to halt deadly meningitis spread
-
EU lawmakers back ban on sexualised AI deepfakes
-
Stripping Senegal of AFCON title a 'disgrace for Africa' say fans
-
Under Hezbollah fire, people in north Israel hope for better days
-
Iran women's football team cross Turkish border to head home: AFP
-
Fear in central Beirut as Israel strikes, with and without warning
-
'France is wild': Macron to unveil name of Europe's largest warship
-
Arsenal's Trossard says Leverkusen win ideal ahead of League Cup final
-
Israel conducts wave of strikes on Beirut
-
Seven-year term sought for Norway princess's son for alleged rapes
-
US govt says Anthropic AI an 'unacceptable risk' to military
-
Head of victorious Nepal party hails 'win for the country'
-
Brussels touts 'EU Inc.' company status to lure start-ups
-
UN maritime body kicks off emergency talks on Mideast shipping
-
China tech giant Tencent bets on AI agents
-
AFCON stripping of Senegal's title a 'disgrace for Africa' say fans
-
Japan thrash South Korea 4-1 to set up Women's Asian Cup final with Australia
-
Fernandez uncertain over Chelsea future after Champions League exit
-
Iran women's football team arrive in eastern Turkey, heading home
-
Russia slams Oscar-winning anti-Putin documentary
-
Mass burials expected for victims of Kabul drug rehab centre strike
-
Celtic keeper Schmeichel fears shoulder injury could end his career
-
Israelis shelter with pets from threat of Iran missiles
-
Deadly strikes across Mideast as Iran vows revenge on slain security chief
-
Japan, S. Korea petrochemical industry slows output on Iran war
-
Stocks extend gains, oil sinks as US, Israel, Iran press on strikes
-
Record setters Duplantis, Hodgkinson headline Torun world indoors
-
Chinese visitors to Japan plunge 45.2% in February
-
BTS light stick prices surge ahead of comeback concert
-
'Special human' Slipper to break Super Rugby appearance record
-
Brussels to unveil 'EU Inc' pan-European company status
-
Iran to hold funeral for slain security chief as it vows vengeance
-
Greenland's teenage boxers throwing punches to survive
-
TotalEnergies faces ruling in Belgian farmer climate case
Abortion pill at the center of a US court battle
A widely used abortion pill is at the center of the latest legal battle in America's ongoing debate over abortion.
The US Supreme Court on Wednesday said that it would weigh in on restrictions imposed by a lower court on the drug mifepristone.
Here is the background on the drug and its use:
- How widespread is abortion pill use? -
According to the Guttmacher Institute, the pill accounted for more than half -- 53 percent -- of the 930,160 abortions documented by the reproductive health research and policy organization in the United States in 2020.
While the number of so-called medication abortions has gone up dramatically in the United States in recent years, it is still not as prevalent as in several European nations.
In France, for example, medication abortions represented 70 percent of the total number of abortions in 2020.
- How does it work? -
The abortion pill is different from the "morning after" pill, which is taken by a woman after sexual intercourse to prevent becoming pregnant.
The abortion pill is taken to induce an abortion once a woman confirms that she is pregnant.
The process in fact involves more than one pill. The first, mifepristone, also known as RU 486, stops a pregnancy from proceeding normally by blocking production of the hormone progesterone.
Another drug, misoprostol, is taken up to 48 hours later and causes cramps, bleeding and the emptying of the uterus.
Abortion pills can be used at home and a medical setting is not required.
- When was the abortion pill approved? -
The US Food and Drug Administration (FDA) gave the green light to mifepristone and misoprostol in 2000 for use up to seven weeks of pregnancy.
It was later approved for use up to 10 weeks of pregnancy, after which a woman would need to undergo an abortion through other means, such as vacuum aspiration.
The average cost of a medication abortion at Planned Parenthood is $580 but it can cost up to $800.
- Is it safe and effective? -
Use of the abortion pill during the specified time period is considered to be safe and effective by medical experts.
Pregnancies are successfully terminated in more than 95 percent of cases where the pill is used, according to studies.
Serious complications -- excessive bleeding, fever, infection or allergic reaction -- which require a medical consult, are rare.
The abortion pill does not work for ectopic pregnancies, which account for around two percent of all pregnancies and occur when a fertilized egg grows outside the uterus.
- Where is the pill available? -
Around 20 US states have banned or severely restricted access to abortions, including medication abortions, since the Supreme Court's ruling in June 2022 overturning the constitutional right to the procedure.
But anti-abortion groups are seeking to restrict access to mifepristone nationwide, including in states where abortion has remained legal.
The case before the Supreme Court concerns limiting the use of mifepristone to the first seven weeks of pregnancy, instead of 10, and blocking it from being distributed by mail.
L.Maurer--VB